ER-positive early-stage breast cancer is associated with risk for late recurrence (more than 5 years after diagnosis). Considering all subtypes of breast cancer, most recurrences occur within the first 5 years after diagnosis. In triple-negative breast cancer, most recurrences happen within 3 years after diagnosis.
Childbearing after treatment for invasive breast cancer does not increase rates of recurrence.
Tamoxifen does reduce the risk for recurrence after diagnosis of hormone receptor–positive breast cancer.
Learn more about breast cancer recurrence risk.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Elwyn C. Cabebe, Stefania Morganti. Fast Five Quiz: The Recurrence Risks for Breast Cancer - Medscape - Feb 06, 2023.
Comments